|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gaschott T and Stein J: Short-chain fatty
acids and colon cancer cells: The vitamin D receptor - butyrate
connection. Recent Results Cancer Res. 164:247–257. 2003.
View Article : Google Scholar
|
|
3
|
Vaziri C, Stice L and Faller DV:
Butyrate-induced G1 arrest results from p21-independent disruption
of retinoblastoma protein-mediated signals. Cell Growth Differ.
9:465–474. 1998.PubMed/NCBI
|
|
4
|
Ruemmele FM, Schwartz S, Seidman EG,
Dionne S, Levy E and Lentze MJ: Butyrate induced Caco-2 cell
apoptosis is mediated via the mitochondrial pathway. Gut.
52:94–100. 2003. View Article : Google Scholar
|
|
5
|
Guilloteau P, Martin L, Eeckhaut V,
Ducatelle R, Zabielski R and Van Immerseel F: From the gut to the
peripheral tissues: The multiple effects of butyrate. Nutr Res Rev.
23:366–384. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Donohoe DR, Collins LB, Wali A, Bigler R,
Sun W and Bultman SJ: The Warburg effect dictates the mechanism of
butyrate-mediated histone acetylation and cell proliferation. Mol
Cell. 48:612–626. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
López de Silanes I, Olmo N, Turnay J,
González de Buitrago G, Pérez-Ramos P, Guzmán-Aránguez A,
García-Díez M, Lecona E, Gorospe M and Lizarbe MA: Acquisition of
resistance to butyrate enhances survival after stress and induces
malignancy of human colon carcinoma cells. Cancer Res.
64:4593–4600. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leslie EM, Deeley RG and Cole SP:
Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2,
and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol.
204:216–237. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lepiarczyk M, Kałuża Z, Bielawska A,
Czarnomysy R, Gornowicz A and Bielawski K: Cytotoxic activity of
octahydropyrazin[2,1-a:5,4-a′]diisoquinoline derivatives in human
breast cancer cells. Arch Pharm Res. 38:628–641. 2015. View Article : Google Scholar
|
|
10
|
Han YS, Lee JH and Lee SH: Antitumor
effects of fucoidan on human colon cancer cells via activation of
Akt signaling. Biomol Ther (Seoul). 23:225–232. 2015. View Article : Google Scholar
|
|
11
|
Lim SJ, Choi HG, Jeon CK and Kim SH:
Increased chemoresistance to paclitaxel in the MCF10AT series of
human breast epithelial cancer cells. Oncol Rep. 33:2023–2030.
2015.PubMed/NCBI
|
|
12
|
Song HM, Park GH, Eo HJ, Lee JW, Kim MK,
Lee JR, Lee MH, Koo JS and Jeong JB: Anti-proliferative effect of
naringenin through p38-dependent downregulation of cyclin D1 in
human colorectal cancer cells. Biomol Ther (Seoul). 23:339–344.
2015. View Article : Google Scholar
|
|
13
|
Zhang R, Pan X, Huang Z, Weber GF and
Zhang G: Osteopontin enhances the expression and activity of MMP-2
via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines.
PLoS One. 6:e238312011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cook KL, Shajahan AN, Wärri A, Jin L,
Hilakivi-Clarke LA and Clarke R: Glucose-regulated protein 78
controls cross-talk between apoptosis and autophagy to determine
antiestrogen responsiveness. Cancer Res. 72:3337–3349. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gonçalves P and Martel F: Butyrate and
colorectal cancer: The role of butyrate transport. Curr Drug Metab.
14:994–1008. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barrasa JI, Santiago-Gómez A, Olmo N,
Lizarbe MA and Turnay J: Resistance to butyrate impairs bile
acid-induced apoptosis in human colon adenocarcinoma cells via
up-regulation of Bcl-2 and inactivation of Bax. Biochim Biophys
Acta. 1823:2201–2209. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Derjuga A, Richard C, Crosato M, Wright
PS, Chalifour L, Valdez J, Barraso A, Crissman HA, Nishioka W,
Bradbury EM, et al: Expression of p21Waf1/Cip1 and cyclin D1 is
increased in butyrate-resistant HeLa cells. J Biol Chem.
276:37815–37820. 2001.PubMed/NCBI
|
|
18
|
Zhang Y, Wang Z, Ahmed F, Banerjee S, Li Y
and Sarkar FH: Down-regulation of Jagged-1 induces cell growth
inhibition and S phase arrest in prostate cancer cells. Int J
Cancer. 119:2071–2077. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ley R, Balmanno K, Hadfield K, Weston C
and Cook SJ: Activation of the ERK1/2 signaling pathway promotes
phosphor-ylation and proteasome-dependent degradation of the
BH3-only protein, Bim. J Biol Chem. 278:18811–18816. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luciano F, Jacquel A, Colosetti P, Herrant
M, Cagnol S, Pages G and Auberger P: Phosphorylation of Bim-EL by
Erk1/2 on serine 69 promotes its degradation via the proteasome
pathway and regulates its proapoptotic function. Oncogene.
22:6785–6793. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Serpa J, Caiado F, Carvalho T, Torre C,
Gonçalves LG, Casalou C, Lamosa P, Rodrigues M, Zhu Z, Lam EWF, et
al: Butyrate-rich colonic microenvironment is a relevant selection
factor for metabolically adapted tumor cells. J Biol Chem.
285:39211–39223. 2010. View Article : Google Scholar : PubMed/NCBI
|
